How Should a Safe and Effective COVID‑19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton

Recently, there have been encouraging commitments around the world to manufacture coronavirus disease 2019 (COVID-19) vaccines in anticipation of results from clinical studies. Continue Reading

Educating the Next Leaders in Applied HEOR: Jefferson’s Unique Approach

In this blog, Dr. Peeples interviews Dr. Vittorio Maio, Jefferson’s AHEOR Program Director and they discuss how his team has devised a curriculum and an online experience that enables working professionals to enhance their career while maintaining their full-time job. Continue Reading

Payer Contact in a “Contactless” World: Achieving Early Engagement

In the first of a two-part series on early engagement with payers, Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Allen Lising, Managing Director of FormularyDecisions at Xcenda to discusss this innovative platform. Continue Reading

Taking Action from RWE Analytics: Use of Health Insights Dataset Reveal Underdiagnosis and Care Gaps in NASH and NAFLD

Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic steatohepatitis), has become a major public health concern, affecting about one in four Americans (Younossie 2018). Its increasing prevalence parallels rising rates of obesity and type 2 diabetes. Continue Reading